COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

Jean Y.J. Wang Elected to the American Academy of Arts & Sciences

 

April 19, 2011  |  

UCSD researcher noted for her studies of cell signaling and cancer genetics

Jean Yin Jen Wang, PhD, professor of medicine and biology in the University of California, San Diego School of Medicine, was elected today with 211 other distinguished scientists, scholars, writers, artists, business and civic leaders to the American Academy of Arts and Sciences.

Jean Wang

Jean Wang, Phd

Wang, who is also associate director for basic research at the UCSD Moores Cancer Center, studies how normal cells recognize and respond to external and internal signals calling for growth, quiescence, differentiation and apoptosis (cell death) and how cancer cells ignore, circumvent or eliminate these normal regulatory pathways, leading to uncontrolled growth and spread of the disease.

Wang joins an esteemed list of scientists in the newly elected 2011 class, among them:  astronomer Paul Butler, discoverer of more than 330 planets; public health specialist and former Mexican Minister of Health Julio Frenk; geographer Ellen Mosley-Thompson, who has led expeditions to Antarctica and Greenland; David Page, whose genome sequencing work has advanced understanding of human reproduction; theoretical computer scientists Avi Wigderson; and Nobel laureates Ei-Ichi Negish (chemistry) and H. David Politzer (physics).

The 2011 class will be inducted at a ceremony Oct. 1 at the Academy's headquarters in Cambridge, Mass.

The American Academy of Arts & Sciences was founded in 1780 by John Adams, James Bowdoin, John Hancock and others. Among its members: George Washington, Benjamin Franklin, Daniel Webster, Ralph Waldo Emerson, Albert Einstein and Winston Churchill. Current membership includes more than 250 Nobel laureates and 60 Pulitzer Prize winners.

# # #

Media Contact: Scott LaFee, 619-543-6163, slafee@ucsd.edu


Related Specialties

Cancer


Media Contact

Share This Article


Related News

3/2/2021
Researchers at UC San Diego School of Medicine and elsewhere have identified a new drug that could prevent AD by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques.
3/2/2021
Researchers at UC San Diego Health see a possible way to detect heart disease through the eye.
3/1/2021
A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality ...
2/25/2021
UC San Diego was awarded five COVID-19 Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health totaling nearly $33 million, which will fund efforts that range from manag ...



Follow Us